Volume 4, Issue 3, September 2020, Page: 99-103
Lipid Profile and Prevalence of Dyslipidemia in Hypertensive Patients at the Kara University Hospital Center (Togo)
Tchaa Tcherou, Department of Cardiology, University Teaching Hospital of Kara, Kara, Togo
Komlavi Yayehd, Department of Cardiology, University Teaching Hospital of Campus, Lomé, Togo
Tchalla Yowdéma Abena, Department of Cardiology of Regional Hospital of Kara Tomdè, Kara, Togo
Abalo Mario Bakai, Department of Cardiology, University Teaching Hospital of Kara, Kara, Togo
Koku Languede, Department of Cardiology of Regional Hospital of Tsevié, Tsevié, Togo
Soulemane Pessinaba, Department of Cardiology, University Teaching Hospital of Campus, Lomé, Togo
Doguénsaga Borgatia Atta, Department of Cardiology of Regional Hospital of Sokode, Sokode, Togo
Machihude Pio, Department of Cardiology, University Teaching Hospital of Sylvanus Olympio, lomé, Togo
Soodougoua Baragou, Department of Cardiology, University Teaching Hospital of Sylvanus Olympio, lomé, Togo
Findibe Damorou, Department of Cardiology, University Teaching Hospital of Campus, Lomé, Togo
Received: May 27, 2020;       Accepted: Jun. 17, 2020;       Published: Jul. 4, 2020
DOI: 10.11648/j.ccr.20200403.14      View  62      Downloads  20
Abstract
Dyslipidemia, a primary or secondary pathological modification of serum lipids, is one of the major risk factors for cardiovascular disease. It is currently very common in the populations of the developing countries due to changing dietary and behavioral habits. The objective of this study was to determine the prevalence of dyslipidemia in hypertensive patients received in cardiology consultations at the Kara University Hospital Center. This is a descriptive and cross-sectional study. It included all hypertensive patients received during the study period (January to December 2019), who were able to perform a lipid assessment. The sample was taken on an empty stomach and assayed on a "SELECTRA ProS" automaton using "HELITech clinical system" reagents. The standards: Total cholesterol < 2g/l, HDL > 0.4 g/l (men and women), LDL < 1.3 g/l and triglycerides < 1.5 g/l. Dyslipidemia is defined by the disturbance of at least one of the lipid balance fractions (HDL, LDL and triglycerides). Data analysis was performed by Epi info 7. The prevalence of dyslipidemia was 55.2% with 28.4% of hypo HDL cholesterol, 29% of hyper LDL cholesterol and 21.9% of hypertriglyceridemia. This prevalence is higher in women (59%) than in men (48.5%). Advanced age, obesity and especially abdominal obesity are factors correlated with a high rate of dyslipidemia. Total hypercholesterolemia was found in 34.4% of cases. The prevalence of dyslipidemia is very high in hypertensive people in our environment. It is more frequent in women than in men.
Keywords
Hypertension, Dyslipidemia, Kara UHC
To cite this article
Tchaa Tcherou, Komlavi Yayehd, Tchalla Yowdéma Abena, Abalo Mario Bakai, Koku Languede, Soulemane Pessinaba, Doguénsaga Borgatia Atta, Machihude Pio, Soodougoua Baragou, Findibe Damorou, Lipid Profile and Prevalence of Dyslipidemia in Hypertensive Patients at the Kara University Hospital Center (Togo), Cardiology and Cardiovascular Research. Vol. 4, No. 3, 2020, pp. 99-103. doi: 10.11648/j.ccr.20200403.14
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Thiombiano LP, Mbaye A, Sarr SA, Ngaide AA, Kane Ab, Diao M, Kane Ad et al. Prévalence de la dyslipidémie dans la population rurale de Guéoul (Sénégal). Annales de cardiologie et d’angéiologie 2016 (65); 77-80.
[2]
Jisieike-Onuigbo NN, Unuigbe EI, Kalu OA, Oguejiofor CO, Onuigbo PC. Prevalence of dyslipidemia among adult diabetic patients with overt diabetic nephropathy in Anambra state South-East Nigeria. Nigerian Journal of Clinical Practice 2011; 14 (2): 171-175.
[3]
Ducobu J. Recommandations Européennes et Belges pour le diagnostic et le traitement des dyslipidémies. 4ème Edition 2004.
[4]
Bongard V, Ruidavets JB, Arveiler D et al. Three quarters of coronary heart disease is attributable to conventional modifiable cardiovascular risk factors in a French Cohort of 7161 men. Eur Heart J 2007; 28 (suppl. 1): 147.
[5]
Yusuf S, Hawken S, Ounpuu S et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
[6]
Bruckert E, Farnier M, Ferrières J. HDL-cholestérol et risque cardiovasculaire: au-delà du LDL. Médecine des maladies Métaboliques - Septembre 2010 - Vol. 4 - N°4.
[7]
R. N’Guetta, H. Yao, A. Ekou, M. P. N’Cho-Mottoh, I. Angoran, M. Tano, C. Konin, I. Coulibaly, J. B. Anzouan-Kacou, R. Seka, A. M. Adoh. Prévalence et caractéristiques des syndromes coronariens aigus dans une population d’Afrique subsaharienne. Annales de Cardiologie et d’Angéiologie 65 (2016); 59-63.
[8]
ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal (2018) 39, 3021–3104.
[9]
WHO. Obesity: preventing and managing the global epidemic. WHO Technical Report Series number 894. World Health Organ Tech Rep Ser 2000; 894: i–xii [1–253].
[10]
Alberti K, George MM, Zimmet P, Shaw J. The metabolic syndrome - a new Worldwide definition. Lancet 2005; 366: 1059–62.
[11]
Ferns G, Keti V, Griffin B. Investigation and management of hypertriglyceridaemia. J Clin Pathol 2008; 61: 1174-83.
[12]
Mbaye A, Yaméogo NV, Kane Ad, Diack A, Ndiaye MB, Diack B, Pessinba S, Thiam A, Dioum M, Hakim R, Diagne D, Kane M, Ndour M, Diao M, Diallo A, Diop SN, Kane A. Profil lipidique et risque cardio-vasculaire du diabétique de type 2 au Sénégal. ANGÉIOLOGIE, 2010, VOL. 62, N° 1; 25-29.
[13]
Dominique Doupa, Abdou Salam Mbengue, Fatou Agne Diallo, Modou Jobe, Arame Ndiaye, Adama Kane, Meissa Touré. Lipid profile frequency and the prevalence of dyslipidaemia from biochemical tests at Saint Louis University Hospital in Senegal. Pan African Medical Journal. 2014; 17: 75 doi: 10.11604/pamj.2014.17.75.3577.
[14]
Damorou F, Yayhed K, Tcherou T, Pessinaba S, Kanda A, Soussou B. Epidémiologie et prise en charge de l’hypertension artérielle au CHU de Kara (Centre de référence de la région septentrionale du Togo). Etude prospective longitudinale de 409 patients. Afrique biomédicale 2009, volume 14 N°4: 95-102.
[15]
Lokrou A. Hyperlipidémie et diabète en Côte d’Ivoire, étude transversale de 132 cas. Médecine d’Afrique Noire 1998; 10: 555-7.
[16]
A. Bachir Cherif, S. Bennouar, A. Bouamra, A. Taleb, F. Hamida, M. Temmar, M. T. Bouafia. Prevalence of diabetes and dyslipidemia in hypertensive patients in the area of Blida (Algeria). Annales de cardiologie et d’angéiologie 2018 (67) 198-203.
[17]
Zhang X, et al. Prevalence of dyslipidemia and associated factors among the hypertensive rural Chinese population. Arch Med Res 2007; 38: 432-439.
[18]
Pedrinellia R, et al. LDL cholesterol and global risk stratification in referred hypertensive patients. Atherosclerosis 2005; 180: 137–43.
[19]
Hana T. AlMajed, Abdulnabi T. AlAttar, Ali A. Sadek, Thaier A. AlMuaili, Obeid A. AlMutairi, Amna S. Shaghouli, Wehad A. AlTorah. Prevalence of dyslipidemia and obesity among college students in Kuwait. Alexandria journal of medecine (2011) 47, 67-71.
[20]
Pessinaba S, Mbaye A, Yabeta GAD et al. Enquête de prévalence des facteurs de risque cardio-vasculaire en population générale à Saint Louis (Sénégal), Ann Cardiol Angeiol (Paris) 2013; 62: 253-8.
[21]
Elasmi M, Fek L, Sanhaj I. Prévalence des facteurs de risque cardio-vasculaires conventionnels dans la population de Grand Tunis. Rev Epidemiol Santé Publique 2009; 2: 87-92.
Browse journals by subject